Longeveron Inc. (LGVN) to Highlight its Advances at ROTH Healthcare Opportunities Conference

Longeveron Inc., a trailblazing clinical-stage biotechnology company LGVN, has announced its participation in the upcoming 3rd Annual ROTH Healthcare Opportunities Conference. This significant event is a platform for healthcare companies and investors to exchange insights and opportunities in the industry. Longeveron, with its headquarters nestled in Miami, Florida, takes pride in its specialized focus on developing innovative cell therapies aimed at addressing severe and age-associated diseases.

Emerging Frontiers in Neuroscience

At the conference, Longeveron’s management is set to contribute to the 'Emerging Frontiers in Neuroscience' panel. Their discussion will delve into the latest advancements and the potential of cell therapies in the field of neuroscience. The representation from Longeveron is poised to offer valuable perspectives, given the company’s commitment to pioneering treatments for critical health issues.

One-on-One Engagements

In addition to the panel participation, Longeveron is gearing up to host one-on-one meetings, often referred to as 1x1s. These intimate sessions provide a unique opportunity for Longeveron to engage directly with attendees, fostering deeper connections and discussions with potential investors, industry experts, and collaborators about the company's cutting-edge research and future prospects.

investment, conference, panel